STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA
Clinical trials for STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New strategy aims to tame common virus threat after stem cell transplants
Disease control OngoingThis study looks at a modified approach to prevent and treat cytomegalovirus (CMV) infection in people who have had a donor stem cell transplant for blood cancers or related disorders. About 153 participants will be monitored to see if delaying or adjusting anti-CMV therapy can s…
Matched conditions: STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New combo aims to supercharge immune system against blood cancer
Disease control OngoingThis study tests whether combining the drug lenalidomide with a vaccine can help people with early-stage chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have high-risk genetic features. Lenalidomide is designed to stop cancer growth and boost the immune…
Matched conditions: STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC